Screener
Sionna Therapeutics SION Business Segments — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| External research and development expenses(1) | $12,931 | $9,978 |
| Personnel-related expenses, excluding stock-based compensation | 3,479 | 2,383 |
| Facility and information technology allocated expenses | 485 | 440 |
| General and administrative expenses: | ||
| Personnel-related expenses, excluding stock-based compensation | 3,865 | 2,232 |
| General corporate and facility expenses(2) | 1,986 | 1,943 |
| Other segment items(3) | 4,033 | (494) |
| Net loss | $26,779 | $16,482 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's business segments — other segment items?
- Sionna Therapeutics (SION) reported business segments — other segment items of $4.03M in Q1 2026.
- How has Sionna Therapeutics's business segments — other segment items changed year-over-year?
- Sionna Therapeutics's business segments — other segment items increased by 916.4% year-over-year, from -$494K to $4.03M.
- What does business segments — other segment items mean?
- Encompasses miscellaneous income or expense items specific to a business segment that do not fall into standard operating categories like R&D or personnel costs. This metric captures non-recurring or peripheral financial impacts that affect the segment's bottom line. It is used to identify unique operational variances that deviate from core business activities.
Ask your AI about Sionna Therapeutics's business segments — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude